Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteasome inhibition therapies in childhood cancer.
Zaman F, Fadeel B, Sävendahl L. Zaman F, et al. Among authors: fadeel b. Leukemia. 2008 Apr;22(4):883-4; author reply 884-5. doi: 10.1038/sj.leu.2404997. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972955 No abstract available.
Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.
Ottosson-Wadlund A, Ceder R, Preta G, Pokrovskaja K, Grafström RC, Heyman M, Söderhäll S, Grandér D, Hedenfalk I, Robertson JD, Fadeel B. Ottosson-Wadlund A, et al. Among authors: fadeel b. Mol Pharmacol. 2013 Jan;83(1):245-55. doi: 10.1124/mol.112.080788. Epub 2012 Oct 23. Mol Pharmacol. 2013. PMID: 23093495
Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment.
Zaman F, Zhao Y, Celvin B, Mehta HH, Wan J, Chrysis D, Ohlsson C, Fadeel B, Cohen P, Sävendahl L. Zaman F, et al. Among authors: fadeel b. FASEB J. 2019 Apr;33(4):4962-4974. doi: 10.1096/fj.201801741R. Epub 2019 Jan 18. FASEB J. 2019. PMID: 30657335 Free PMC article.
Our data may open for clinical studies exploring a new possible strategy to prevent GC-induced bone growth impairment by cotreating with HN.-Zaman, F., Zhao, Y., Celvin, B., Mehta, H. H., Wan, J., Chrysis, D., Ohlsson, C., Fadeel, B., Cohen, P., Savendahl, L. …
Our data may open for clinical studies exploring a new possible strategy to prevent GC-induced bone growth impairment by cotreating with HN. …
297 results